Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Int J Radiat Oncol Biol Phys ; 92(3): 667-74, 2015 Jul 01.
Artigo em Inglês | MEDLINE | ID: mdl-25892583

RESUMO

PURPOSE: Predictive assays for acute radiation toxicities would be clinically relevant in radiation oncology. We prospectively examined the predictive role of the survival fraction at 2 Gy (SF2) and of γH2AX (double-strand break [DSB] DNA marker) expression kinetics in peripheral blood mononuclear cells (PBMCs) from cancer patients before radiation therapy. METHODS AND MATERIALS: SF2 was measured with Trypan Blue assay in the PBMCs from 89 cancer patients undergoing radiation therapy at 4 hours (SF2[4h]) and 24 hours (SF2[24h]) after ex vivo irradiation. Using Western blot analysis and band densitometry, we further assessed the expression of γH2AX in PBMC DNA at 0 hours, 30 minutes, and 4 hours (33 patients) and 0 hour, 4 hours, and 24 hours (56 patients), following ex vivo irradiation with 2 Gy. Appropriate ratios were used to characterize each patient, and these were retrospectively correlated with early radiation therapy toxicity grade. RESULTS: The SF2(4h) was inversely correlated with the toxicity grade (P=.006). The γH2AX-ratio(30min) (band density of irradiated/non-irradiated cells at 30 minutes) revealed, similarly, a significant inverse association (P=.0001). The DSB DNA repair rate from 30 minutes to 4 hours, calculated as the relative RγH2AX-ratio (γH2AX-ratio(4h)/γH2AX-ratio(30min)) showed a significant direct association with high toxicity grade (P=.01). CONCLUSIONS: Our results suggest that SF2 is a significant radiation sensitivity index for patients undergoing radiation therapy. γH2AX Western blot densitometry analysis provided 2 important markers of normal tissue radiation sensitivity. Low γH2AX expression at 30 minutes was linked with high toxicity grade, suggesting that poor γH2AX repair activity within a time frame of 30 minutes after irradiation predicts for poor radiation tolerance. On the other hand, rapid γH2AX content restoration at 4 hours after irradiation, compatible with efficient DSB repair ability, predicts for increased radiation tolerance.


Assuntos
Quebras de DNA de Cadeia Dupla , Reparo do DNA , Histonas/metabolismo , Linfócitos/efeitos da radiação , Neoplasias/radioterapia , Tolerância a Radiação , Biomarcadores/metabolismo , Western Blotting , Núcleo Celular/metabolismo , Sobrevivência Celular/efeitos da radiação , Feminino , Humanos , Leucócitos Mononucleares/metabolismo , Leucócitos Mononucleares/efeitos da radiação , Linfócitos/metabolismo , Masculino , Microscopia Confocal , Pessoa de Meia-Idade , Análise Multivariada , Neoplasias/sangue , Valor Preditivo dos Testes , Estudos Prospectivos , Tolerância a Radiação/genética , Fatores de Tempo
2.
J Sports Sci ; 24(8): 849-54, 2006 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-16815779

RESUMO

Although angiogenetic therapy using recombinant growth factors holds much hope for the treatment of ischaemic diseases, there are still many unanswered questions, including the method of administration, the correct dose of these factors, and the duration of the therapeutic approach. Exercise has also been suggested to induce neovascularizaiton in muscles. We evaluated the angiogenetic effects of the intramuscular administration of basic-fibroblast growth factor (b-FGF) and acidic-fibroblast growth factor (a-FGF) in rat heart, compared with rats who exercised daily. In conclusion, both the intramuscular administration of b-FGF and exercise increased significantly angiogenesis in the heart in contrast to the intramuscular administration of a-FGF, which was ineffective.


Assuntos
Vasos Coronários/efeitos dos fármacos , Fator 1 de Crescimento de Fibroblastos/farmacologia , Fator 2 de Crescimento de Fibroblastos/farmacologia , Neovascularização Fisiológica/efeitos dos fármacos , Condicionamento Físico Animal , Animais , Coração/efeitos dos fármacos , Injeções Intramusculares , Masculino , Miocárdio/patologia , Ratos , Ratos Wistar
3.
Anticancer Res ; 26(1A): 243-7, 2006.
Artigo em Inglês | MEDLINE | ID: mdl-16475704

RESUMO

BACKGROUND: NSC 290205 (A) is a hybrid synthetic antitumor ester, which combines a D-lactam derivative of androsterone and nitrogen mustard. In this study, the antitumor activity of A in combination with ADR (AHOP) was investigated in comparison with the standard CHOP regimen. MATERIALS AND METHODS: PAN02 adenocarcinoma was used in this study. C57Bl mice were used for chemotherapy evaluation. The activity was assessed from the inhibition of tumor growth and the oncostatic parameter T/C%. RESULTS: Treatment with A or cyclophosphamide produced almost equal borderline activity. Moreover, both the CHOP and AHOP regimens showed significant and comparable antitumor effects. AHOP caused the maximum effect, inhibiting tumor growth by 56.8%. CHOP was less effective, producing 47.7% tumor inhibition. CONCLUSION: It is very likely that the D-lactamic steroid (androstan) alkylator forA, containing the amide group -NH-CO-, combined with ADR which intercalates between DNA base-pairs, is the explanation for the higher activity of AHOP as compared to CHOP.


Assuntos
Protocolos de Quimioterapia Combinada Antineoplásica/farmacologia , Azasteroides/farmacologia , Carcinoma Ductal Pancreático/tratamento farmacológico , Compostos de Mostarda Nitrogenada/farmacologia , Neoplasias Pancreáticas/tratamento farmacológico , Animais , Protocolos de Quimioterapia Combinada Antineoplásica/administração & dosagem , Azasteroides/administração & dosagem , Linhagem Celular Tumoral , Ciclofosfamida/administração & dosagem , Ciclofosfamida/farmacologia , Doxorrubicina/administração & dosagem , Feminino , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Compostos de Mostarda Nitrogenada/administração & dosagem , Prednisona/administração & dosagem , Vincristina/administração & dosagem
4.
In Vivo ; 18(6): 825-9, 2004.
Artigo em Inglês | MEDLINE | ID: mdl-15646828

RESUMO

UNLABELLED: Although angiogenetic therapy using recombinant growth factors holds much hope for the treatment of ischemic diseases, there are still unanswered questions including the method, doses or duration of therapeutic approach. We evaluated the angiogenetic effects of vascular endothelial growth factor (VEGF) on rat heart and gastrocnemius muscles when this was administered intramuscularly and compared them to those obtained from rats, which exercised daily. CONCLUSION: Both daily swimming exercise and intramuscular administration of VEGF increased angiogenesis in rat heart, even though exercise alone was the only one that increased angiogenesis quite significantly. The combined protocol (administration of growth factor and exercise) led to an increase of angiogenesis in cardiac muscles. In contrast, there was no effect on the lateral gastrocnemius muscle either by VEGF or exercise, whereas these together induced angiogenesis locally at the site of injection.


Assuntos
Coração/efeitos dos fármacos , Músculo Esquelético/efeitos dos fármacos , Miocárdio , Neovascularização Fisiológica/efeitos dos fármacos , Condicionamento Físico Animal , Fator A de Crescimento do Endotélio Vascular/farmacologia , Animais , Vasos Coronários/efeitos dos fármacos , Injeções Intramusculares , Músculo Esquelético/irrigação sanguínea , Condicionamento Físico Animal/fisiologia , Ratos , Ratos Wistar , Natação/fisiologia , Fator A de Crescimento do Endotélio Vascular/administração & dosagem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA